Registrations:
|
|
|
- Laurel Richards
- 8 years ago
- Views:
Transcription
1 Chair: Rafael Rosell Under the Auspices of: Registrations:
2 Thursday, 21 st of November :00-10:00 CLINICAL SESSION Isabel lbover Fundación Hospital Son Llàtzer, Palma de Mallorca Mª Dolores Isla Hospital Clínico Univ. Lozano Blesa, Zaragoza 08:00-08:15 New developments in SCLC Edurne Arriola Hospital del Mar, Barcelona 08:15-08:30 Imaging techniques for assessing systemic therapies Juan Arenas 08:30-08:45 New combinations and concurrent CT/RT in Locally Advanced NSCLC Natividad Martínez Hospital General Universitario, Elche (Alicante) 08:45-09:00 Comprehensive strategies in the treatment of metastatic NSCLC Luis Paz-Ares Hospital Universitario Virgen del Rocío, Sevilla 09:00-09:15 Anti-angiogenesis in NSCLC achievements and new deals (ANGIOMET Trial) Delvys Rodríguez Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria 09:15-09:30 Special populations in NSCLC: elderly, PS2 María Jové ICO, Hospital de Bellvitge, L Hospitalet de Llobregat (Barcelona) 09:30-09:45 Immunotherapy in NSCLC: anti-pd1 and anti-pdl1 Santiago Ponce Hospital Universitario 12 de Octubre, Madrid 09:45-10:00 Conclusions 10:30 WELCOME Rafael Rosell 10:40-11:30 SESSION 1: UPDATES ON CLINICAL TRIALS Rosario García Campelo Complejo Hospitalario Universitario, A Coruña Jürgen Wolf Center for Integrated Oncology, Cologne (Germany) 10:40-10:50 BELIEF Enric Carcereny
3 10:50-11:00 GOAL Rosario García Campelo Complejo Hospitalario Universitario, A Coruña 11:00-11:10 EUCROSS Jürgen Wolf Center for Integrated Oncology, Cologne (Germany) 11:10-11:20 NVALT trial in second line squamous cell carcinoma with FGFR1 amplification Harry J. M. Groen University Medical Center Groningen, Groningen (The Netherlands) 11:20 11:30 Foretinib/erlotinib in EGFR WT NSCLC, second line resistant EGFR mutated patients and ROS1 positive, crizotinib resistant patients Niki Karachaliou 11:30-12:40 SESSION 2: CLINICAL IMPLICATIONS OF RESEARCH IN PATHOLOGY AND LUNG CANCER BIOLOGY Egbert F. Smit VU University Medical Center, Amsterdam (The Netherlands) José L. Ramírez 11:30-11:40 Multi-assay genotyping of druggable driver mutations Katharina König Uniklinik Köln, Cologne (Germany) 11:40-11:50 Relevance of FISH for ALK, ROS1 and RET translocations Hans-Ulrich Schildhaus University Hospital Göttingen, Göttingen (Germany) 11:50-12:00 Concordance of FISH and PCR for EML4-ALK Cristina Teixidó Pangaea Biotech, Barcelona 12:00-12:10 EML4-ALK and other mutations in blood platelets Thomas Würdinger VU University Medical Center, Amsterdam (The Netherlands) 12:10-12:20 MLPA assay for multiplexing mutations, copy numbers and fusion transcripts José L. Ramírez ICO, Hospital Universitario Germans Trias i Pujol, Badalona (Barcelona) 12:20-12:40 Questions and answers. Conclusions Egbert F. Smit VU University Medical Center, Amsterdam (The Netherlands) KEYNOTE LECTURE 12:40-13:10 Using tumor growth rates to differentiate cancer therapies Antonio Tito Fojo National Cancer Institute, Center for Cancer Research,Bethesda (Maryland, USA) 13:10-14:10 Lunch
4 Thursday, 21 st of November :10-14:40 SESSION 3: BREAKTHROUGHS IN SCLC AND MESOTHELIOMA Rolf A. Stahel University Hospital Zurich, Zurich (Switzerland) Felipe Cardenal ICO, Hospital Duran i Reynals, L Hospitalet de Llobregat (Barcelona) 14:10-14:20 HIPPO/YAP pathway for targeted therapy Emanuela Felley-Bosco University Hospital Zurich, Zurich (Switzerland) 14:20-14:30 State of the art in mesothelioma management Rolf A. Stahel University Hospital Zurich, Zurich (Switzerland) 14:30-14:40 Improving curability in SCLC: A feasible objective? Pilar Lianes Hospital de Mataró, Mataró (Barcelona) 14:40-15:40 SESSION 4: TARGETED THERAPIES AND NOVEL AGENTS IN STAGE IV NSCLC Manuel Dómine Fundación Jiménez Díaz, Madrid Enriqueta Felip Hospital General Vall d Hebron, Barcelona 14:40-14:50 Whole genome sequencing for precise targeted therapy Trever G. Bivona University of California, San Francisco (California, USA) 14:50-15:00 Understanding resistance to EGFR TKIs in EGFR mutant NSCLC through a serial rebiopsy program Margarita Majem Hospital de la Santa Creu i Sant Pau, Barcelona 15:00-15:10 c-met mab development in lung cancer Volker Wacheck Lilly (Austria) 15:10-15:20 Targeted therapy in NSCLC driven by HER2 insertions Solange Peters Lausanne Cancer Center, Centre Hospitalier Universitaire Vaudois Lausanne (Switzerland) 15:20-15:40 Questions and answers. Conclusions Enriqueta Felip Hospital General Vall d Hebron, Barcelona 15:40-16:20 SESSION 5: LOCALLY ADVANCED NSCLC Wilfried Eberhardt West German Cancer Center. University of Essen Medical School, Essen (Germany) Pilar Garrido Hospital Universitario Ramón y Cajal, Madrid
5 15:40-15:50 Chemoradiotherapy: Déjà vu or a new reality? Wilfried Eberhardt West German Cancer Center. University of Essen Medical School Essen (Germany) 15:50-16:00 State of the art in treatment Pilar Garrido Hospital Universitario Ramón y Cajal, Madrid 16:00-16:10 Integration of novel targeted therapies into radiotherapy for lung cancer Mariano Provencio Hospital Universitario Puerta de Hierro, Majadahonda (Madrid) 16:10-16:20 Questions and answers. Conclusions Arturo Navarro ICO, Hospital Duran i Reynals, L Hospitalet de Llobregat (Barcelona) 16:20-16:40 Coffee break 16:40-18:00 SESSION 6: ADVANCES IN EARLY STAGE NSCLC Florentino Hernando Trancho Hospital Clínico Universitario San Carlos, Madrid 16:40-16:50 Management of stage I NSCLC patients Enriqueta Felip Hospital General Vall d Hebron, Barcelona 16:50-17:00 Adjuvant chemotherapy in stage I high risk patients José Ramón Jarabo Hospital Clínico Universitario San Carlos, Madrid 17:00-17:10 Customized adjuvant chemotherapy in stage II and III - the SCAT experience 17:10-17:20 State of the art of adjuvant chemotherapy in Stage II and III NSCLC patients Ángel Artal Hospital Universitario Miguel Servet, Zaragoza 17:20-17:30 State of the art in surgery for early NSCLC. Does the number of resected lymph nodes matter? Laura Romero Hospital General Vall d Hebron, Barcelona 17:30-17:40 CTCs in monitoring resected NSCLC Andreas-Claudius Hoffmann West German Cancer Center. Uniklinikum Essen, Essen (Germany) 17:40-18:00 Questions and answers. Conclusions Javier de Castro Hospital Universitario La Paz, Madrid
6 Friday, 22 nd of November :00-08:30 SLCG PLENARY SESSION 08:30-08:45 PLENARY LECTURE 08:30-08:45 Moving forward to synthetic lethal approaches for improving survival in NSCLC Rafael Rosell 08:45-09:55 SESSION 7: MOLECULAR SCREENING FOR SYNTHETIC LETHALITY APPROACHES Niki Karachaliou Trever G. Bivona University of California, San Francisco (California, USA) 08:45-08:55 KRAS mutations Rolf A. Stahel University Hospital Zurich, Zurich (Switzerland) 08:55-09:05 BRAF mutations José M. Sánchez Hospital Universitario de La Princesa, Madrid 09:05-09:15 Predicting resistance by selection of signaling pathways Niki Karachaliou 09:15-09:25 Combination targeted therapy in EGFR mutant patients Trever G. Bivona University of California, San Francisco (California, USA) 09:25-09:35 Combination targeted therapy in EML4-ALK translocated patients Santiago Viteri 09:35-09:55 Questions & answers. Conclusions Santiago Ponce Hospital Universitario 12 de Octubre, Madrid 09:55-10:15 Coffee break KEYNOTE LECTURE 10:15-10:45 Improving the activity of epigenetic therapies Susan E. Bates National Cancer Institute, Center for Cancer Research, Bethesda (Maryland, USA) 10:45-10:55 SESSION 8: STATE OF THE ART IN TRANSLATIONAL RESEARCH Miguel A. Molina Mariano Provencio Hospital Universitario Puerta de Hierro, Majadahonda (Madrid)
7 10:45-10:55 p53 mutational analysis for clinical applications Miguel A. Molina 10:55-11:05 Transcriptional regulators for refinement of lung cancer subtypes Cristina Teixidó Pangaea Biotech, Barcelona 11:05-11:15 From the bench to the bed: the unmet need for progress Egbert F. Smit VU University Medical Center, Amsterdam (The Netherlands) 11:15-11:25 Lessons from the BREC study: opportunities remain for customizing chemotherapy Manuel Cobo Hospital Universitario Carlos Haya, Málaga 11:25 11:35 Elderly patients: how old is too old for translational research? 70, 90? Alain Vergnenègre Cluzeau University Hospital, Limoges (France) 11:35-11:55 Questions and answers. Conclusions Noemí Reguart Hospital Clínic Universitari, Barcelona 11:55 12:25 SESSION 9: CRUCIAL ROLE OF THE THORACIC SURGEON Laureano Molins Hospital Clínic, Barcelona Nicolás Moreno Hospital Universitario Virgen del Rocío, Sevilla 11:55-12:05 Surgical implications of the new pathological classification of adenocarcinoma Íñigo Royo Hospital Universitario Miguel Servet, Zaragoza 12:05-12:15 VATS resections in NSCLC: Oncological Results Pedro López de Castro Hospital Universitario Germans Trias i Pujol, Badalona (Barcelona) 12:30-12:25 Surgical management of metachronic and synchronic second primary lung tumors Íker López Sanz Hospital General Vall d Hebrón, Barcelona 12:25-12:40 PLENARY LECTURE 12:25-12:40 DNA stability and cisplatin resistance in NSCLC Ken O Byrne Queensland University of Technology, Brisbane (Queensland, Australia) 12:40-12:50 Closing remarks Rafael Rosell Hospital General Universitario de Alicante, Alicante
8 VENUE Auditori AXA Avda. Diagonal, Barcelona (Spain) LANGUAGE Lectures will be delivered in English or Spanish. CREDITS Accredited by the European Society for Medical Oncology Educational Committee Working Group for its medical oncology certification approval program with 10 ESMO-MORA category 1 points. ORGANIZING & SCIENTIFIC COMMITTEE Carlos Camps, Hospital General Universitario, Valencia Enric Carcereny, Felipe Cardenal, ICO, Hospital Duran i Reynals, L Hospitalet de Llobregat (Barcelona) Javier de Castro, Hospital Universitario La Paz, Madrid Manuel Cobo, Hospital Universitario Carlos Haya, Málaga Manuel Dómine, Fundación Jiménez Díaz, Madrid Rosario García Campelo, Complejo Hospitalario Universitario, A Coruña Florentino Hernando-Trancho, Hospital Clínico Universitario San Carlos, Madrid Dolores Isla, Hospital Clínico Universitario Lozano Blesa, Zaragoza Eloísa Jantús, Hospital General Universitario, Valencia Margarita Majem, Hospital de la Santa Creu i Sant Pau, Barcelona, Teresa Morán, Mariano Provencio, Hospital Universitario Puerta de Hierro, Majadahonda (Madrid) Noemí Reguart, Hospital Clínic Universitari, Barcelona Rafael Rosell, José Javier Sánchez, Universidad Autónoma de Madrid José Miguel Sánchez, Hospital Universitario de la Princesa, Madrid Miquel Taron, Pangaea Biotech, Barcelona MAJOR SPONSORS OTHER SPONSORS CONFERENCE SECRETARIAT Monasterios de Suso y Yuso 34, Madrid Tel.: gecp2013@doctaforum.com
Thursday, 20th November
Thursday, 20th November 10.30-10.45 Opening remarks Carlos Camps, Hospital General Universitario, Valencia Past, present and future of the Spanish Lung Cancer Group SESSION 1 Cancer biology and lung cancer
Chairs: Mariano Provencio. Hospital Univ. Puerta de Hierro, Majadahonda (Madrid) Rafael Rosell
Chairs: Mariano Provencio Rafael Rosell ICO, Hospital Universitario Germans Trias i Pujol, Badalona (Barcelona) Under the auspices of: Registrations: www.doctaforum.com/gecp THURSDAY, 26 TH NOVEMBER NEW
Registrations: www.doctaforum.com/gecp
Organized by Registrations: www.doctaforum.com/gecp CHAIR Rafael Rosell, ICO, Hospital Univ. Germans Trias i Pujol, Badalona (Barcelona) Under the Auspicies of: Thursday, 17 th November 2011 SESSION 1:
Retrieval Centres for HPC-M and HPC-A
A Coruña - (Cod: ES0061) COMPLEXO HOSPITALARIO UNIVERSITARIO JUAN CANALEJO Estrada das Xubias, s/n - 15006 Alcalá de Henares MADRID - (Cod: ES0208) HOSPITAL UNIV. PRINCIPE ASTURIAS Carretera Alcalá-Meco,
Pharmacogenomic Approaches. Luis Paz-Ares Hospital Universitario Virgen del Rocio Seville, Spain
Pharmacogenomic Approaches Luis Paz-Ares Hospital Universitario Virgen del Rocio Seville, Spain Pharmacogenetics & Pharmacogenomics Medicine tailored to the individual Genetic information, including the
Dialnet. Author Identification. Eduardo Bergasa eduardo.bergasa@unirioja.es
Dialnet Author Identification Eduardo Bergasa eduardo.bergasa@unirioja.es Fundación Dialnet! Public non-profit foundation! Spin-off of University of La Rioja! Constitution: 2009! In charge of Dialnet portal
Scientific Committee. Andrés Cervantes (ESMO, GEICO) Antonio González (ESMO, GEICO) Andrés Poveda (ESMO, GEICO) Jan B. Vermorken (ESMO, GEICO)
Under the Auspices of Organized by 10th International Symposium Advanced Ovarian Cancer: Optimal Therapy. Update Valencia, Spain, 6th March 2015 Directors Andrés Poveda Fundación Instituto Valenciano de
Targeted Therapy What the Surgeon Needs to Know
Targeted Therapy What the Surgeon Needs to Know AATS Focus in Thoracic Surgery 2014 David R. Jones, M.D. Professor & Chief, Thoracic Surgery Memorial Sloan Kettering Cancer Center I have no disclosures
Scientific Program. Advances in the Treatment of Digestive Tumours. Symposium. International. Under the auspices of: Accredited by:
Advances in the Treatment of Digestive Tumours Scientific Program 22 International Symposium Barcelona (Spain) 11th and 12th December 2014 HOTEL BARCELÓ SANTS Under the auspices of: FEDERATION OF SPANISH
How To Contact Cotransa
COTRANSA - Key Contact Details Physical address: MADRID (HEAD OFFICE) Avda Central, Parcela 2.5, Naves 1 y 3. 28042 Centro de carga aerea Marid-Barajas Madrid (SPAIN) Tel: +34 917 46 06 80 Fax: +34 913
Nuevas tecnologías basadas en biomarcadores para oncología
Nuevas tecnologías basadas en biomarcadores para oncología Simposio ASEBIO 14 de marzo 2013, PCB Jose Jimeno, MD, PhD Co-Founder / Vice Chairman Pangaea Biotech SL Barcelona, Spain PANGAEA BIOTECH BUSINESS
INDUSTRY-ACADEMIC-CLINICAL FORUM
INDUSTRY-ACADEMIC-CLINICAL FORUM FUTURE TRENDS IN NANOMEDICINE FOR DIAGNOSTICS AND THERAPY IN ONCOLOGY Parc Científic de Barcelona / Barcelona Science Park 25 th of October of 2012 TABLE OF CONTENTS Agenda
13 May 14 May. SESSION 2.- Advances in hearing loss research II Chair: Andrew Forge
13 May 14 May 15:00-17:00 Registration 15:45-16:00 Welcome on behalf of the organizers José María Millán. Unit of Genetics La Fé Hospital. CIBERER. Valencia. Spain. 16:00-16:30 Francesc Palau. CIBERER
WORKSHOP IN LUNG CANCER CLINICAL RESEARCH Improving opportunities in the LATAM region
WORKSHOP IN LUNG CANCER CLINICAL RESEARCH Improving opportunities in the LATAM region April 2016 27-30 Santiago - Chile Hotel Diego de Almagro San Pío X 2530, Providencia, Santiago. INFORMATION www.lungcancerworkshop.cl
ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials)
ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials) 3 Integrated Trials Testing Targeted Therapy in Early Stage Lung Cancer Part of NCI s Precision Medicine Effort in
ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC. Thursday 16th April 2015 13:10 14:20 Room C
ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC Thursday 16th April 2015 13:10 14:20 Room C 1 Contents Programme.... 2 Welcome message.... 3 Faculty biographies.... 4 Symposium
HPC authorized transplant centres SPAIN
Last updated: 8/1/08 A Coruña - (Cod: ES0061) COMPLEXO HOSPITALARIO UNIVERSITARIO JUAN CANALEJO Estrada das Xubias, s/n - 15006 ALBACETE - (Cod: ES0062) COMPLEJO HOSPITALARIO Y UNIVERSITARIO DE ALBACETE
1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1
1 page Overview 21 Oct Tuesday 1500 on REGISTRATION 1800 Welcome Reception & Cocktails at the Cape Town International Conference Centre (CTICC) 22 Oct Wednesday 0730 REGISTRATION 0830 OPENING 0900 PLENARY
ETOP European Thoracic Oncology Platform c/o IBCSG Effingerstrasse 40 3008 Bern. Phone +41 31 389 93 91 Fax +41 31 389 92 35. www.etop-eu.
Annual Report 2012 ETOP European Thoracic Oncology Platform c/o IBCSG Effingerstrasse 40 3008 Bern Phone +41 31 389 93 91 Fax +41 31 389 92 35 www.etop-eu.org UBS AG Postfach CH-8098 Zürich Switzerland
Wednesday, February 24 th, 2016
List of Faculty: Nadeem R. Abu-Rustum, Memorial Sloan Kettering Cancer Center. New York, USA Giovanni Aletti, Istituto Europeo di Oncologia. Milan, Italy Natalia Carballo, David Cibula, General University
Wednesday, February 24 th, 2016
List of Faculty: Nadeem R. Abu-Rustum, Memorial Sloan Kettering Cancer Center. New York, USA Giovanni Aletti, Istituto Europeo di Oncologia. Milan, Italy Natalia Carballo, David Cibula, General University
SCIENTIFIC PROGRAMME. Foundation
SCIENTIFIC PROGRAMME Foundation WEDNESDAY *Coffee-breaks will be in the Commercial Exhibition Areas All posters will be displayed on digital screens 4 5 THURSDAY 29 OCTOBER 8:00-9:00h CONGRESS HIGHLIGHTS
Diagnostic and Therapeutic Colonoscopy for Colorectal Neoplasia in the 21st Century: Focus on IBD
Marbella (Spain), January 29th & 30th, 2015 Diagnostic and Therapeutic Colonoscopy for Colorectal Neoplasia in the 21st Century: Preliminary Program Thursday, January 29th 2015 15:45-16:00 Welcome to the
Public-Private Partnerships in early phase clinical research: Spurring access to innovative therapeutics
EPAAC WP8 Research Forum - 2 July, Sofitel Hotel Europe, Brussels Public-Private Partnerships in early phase clinical research: Spurring access to innovative therapeutics JY Blay, Past President EORTC
Diagnostic and Therapeutic Colonoscopy for Colorectal Neoplasia in the 21st Century: Expanding the Scope to IBD
Marbella (Spain), January 17th & 18th, 2013 Diagnostic and Therapeutic Colonoscopy for Colorectal Neoplasia in the 21st Century: Thursday, January 17th 2013 8:45-9:00 Welcome to the Hands-on Course Andres
Liver. Meeting. International. on living donor. transplantation. After Fifteen Years (2000-2015)
Preliminary Program International Meeting ORGANIZED BY Hospital Clínic Hospital Universitari Vall d Hebron Liver Transplantation Units faculty Scientific committee Juan Carlos García-Valdecasas Ramón Charco
Education Session 1. Education Session 2. Inaugural Session
WEDNESDAY 4 NOVEMBER 2015 Education Session 1 09:30-10:30 S1a: Cell and viral vector manufacturing and distribution under GMP Chair: Ana Sanchez S1b: Systems biology: computational methods applied to advanced
Corporate Medical Policy
Corporate Medical Policy Molecular Analysis for Targeted Therapy for Non-Small Cell Lung File Name: Origination: Last CAP Review: Next CAP Review: Last Review: molecular_analysis_for_targeted_therapy_for_non_small_cell_lung_cancer
15 th ASEICA INTERNATIONAL CONGRESS
Sevilla 21-23 october 2015 15 th ASEICA Spanish Society for Cancer Research Hotel NH Collection Sevilla. Avda Diego Martinez Barrio, 8, 41013 Sevilla Organizing Committee President Dr. Pedro Lazo-Zbikowski
ORGANIZERS Fundación para la Investigación Médica Aplicada FIMA Clínica Universidad de Navarra CUN
D International Symposium: Immunostimulatory monoclonal antibodies and immunomodulation: harvesting the crop Fundación Ramón Areces GENERAL INFORMATION DATES OCTOBER 18th 20th VENUE University of Navarra.
RIBS V. Fernando Alfonso MD, PhD, FESC Hospital Universitario La Princesa Madrid.
A Randomized Comparison of Drug-Eluting Balloon Versus Everolimus-Eluting Stent in Patients With Bare-Metal In-Stent Restenosis: The RIBS V Clinical Trial Fernando Alfonso MD, PhD, FESC Hospital Universitario
targeted cancer therapy
LUNG CANCER TREATMENTS What you need to know about... targeted cancer therapy foreword About LUNGevity LUNGevity is the largest national lung cancer-focused nonprofit, changing outcomes for people with
Successes and Limitations of Targeted Cancer Therapy in Lung Cancer
Successes and Limitations of Targeted Cancer Therapy in Lung Cancer Kenichi Suda a, b Tetsuya Mitsudomi a a Division of Thoracic Surgery, Department of Surgery, Kinki University Faculty of Medicine, Osaka-Sayama,
Moving forward, where are we with Clinical Trials?
Moving forward, where are we with Clinical Trials? Dennis A. Wigle Division of Thoracic Surgery Mayo Clinic AATS/STS General Thoracic Surgery Symposium Sunday, April 27 th 2014 2012 MFMER slide-1 Where
European Course Minimally Invasive Spinal Surgery Hands-on Course EUCMISS MADRID 2013 Madrid, 14-15 June, 2013
VENUE Anatomy Laboratory Universidad San Pablo CEU Campus Montepríncipe Madrid European Course Minimally Invasive Spinal Surgery ENDOSCOPIC DISCECTOMY XLIF TLIF TUBULAR APPROACHES PERCUT. PEDICULAR SCREWS
Targeted Therapies in Lung Cancer
Targeted Therapies in Lung Cancer I Edited by: Simona Carnio Thoracic Oncology Division - St Luigi Hospital Orbassano (TO) - Italy Silvia Novello Department of Oncology - University of Torino - Italy Why
Scientific Programme
Scientific Programme Scientific Committee Hilary Calvert UCL Cancer Institute, London, UK Luca Gianni Ospedale San Raffaele IRCCS, Milan, Italy Ana Maria Gonzalez-Angulo Cristiana Sessa Istituto Oncologico
Physical Activity and Health Education in European Schools
Physical Activity and Health Education in European Schools 1 INTRODUCCTION Health(a)ware is an open and dynamic symposium which focuses on Physical Activity as a privileged subject to approach health in
LIST OF CANDIDACIES BROADBAND RESEARCH PROJECTS FOR THE SPANISH E-CULTURENET
LIST OF CANDIDACIES BROADBAND RESEARCH PROJECTS FOR THE SPANISH E-CULTURENET UNIVERSITIES: Complutense University, Madrid - Project 1 Title: Digital Genoma (Researchers: Isidro Moreno Sánchez, Mª Teresa
Gastrointestinal Tumors
Gastrointestinal Tumors CHAIRMEN: A. Carrato B. Massutí ORGANIZING COMMITTEE: A. Abad A. Antón E. Aranda A. Cervantes E. Díaz-Rubio M. Navarro J.M. Tabernero A. Carrato B. Massutí IX TTD International
Promises and challenges of developing new drugs in oncology
3 rd International Michelangelo Conference Promises and challenges of developing new drugs in oncology Chairman: Luca Gianni, Milan I July 2-3, 2015 Venue: Museo della Scienza e della Tecnologia Via San
ADDARIO LUNG CANCER MEDICAL INSTITUTE
ADDARIO LUNG CANCER MEDICAL INSTITUTE Dedicated to catalyzing and accelerating the discovery, development and delivery of new and more effective treatment options for lung cancer patients. Contact: Steven
Promises and challenges of developing new drugs in oncology
3 rd International Michelangelo Conference Promises and challenges of developing new drugs in oncology Chairman: Luca Gianni, Milan I July 2-3, 2015 Venue: Museo della Scienza e della Tecnologia Via San
Talentum Startups An Open Innovation Program. Javier Santiso Managing Director Global Affairs & New Ventures Telefónica, S.A.
Talentum Startups An Open Innovation Program Javier Santiso Managing Director Global Affairs & New Ventures Telefónica, S.A. December, 2013 Unemployment (%) (March, 2013, Eurostat) Innovation is growth
Breast and Lung Cancer Biomarker Research at ASCO: Changing Treatment Patterns
July 2013 Edition Vol. 7, Issue 7 Breast and Lung Cancer Biomarker Research at ASCO: Changing Treatment Patterns By Julie Katz, MPH, MPhil Biomarkers played a prominent role in the research presented in
British Thoracic Oncology Group (BTOG) Annual Report - April 2014 to March 2015
0116 250 2811 dawn.mckinley@uhl-tr.nhs.uk www.btog.org @BTOGORG British Thoracic Oncology Group (BTOG) Annual Report - April 2014 to March 2015 BTOG s Aim BTOG is the multi-disciplinary group for professionals
targeted therapy a guide for the patient
targeted therapy FOR LUNG CANCER a guide for the patient TABLE OF CONTENTS lung cancer basics... 2-3 Gene changes... 4-5 Testing... 7-8 Targeted therapy... 9-11 Drugs Targeting EGFR... 12 Drugs Targeting
Speakers * * ** * * * * * * * * * * * * * * * * ** * * * * * * * ** * * * * ** * * * * * * ** * * * * * * * *
Quasispecies: past, present and future 30 th anniversary VIII Jornada de Virologia SCB November 17-18, 2008 Institut d Estudis Catalans, Barcelona, Spain Speakers Christof Biebricher Albert Bosch Carlos
CLINICAL ONCOLOGY MASTERCLASS IN. 25-29 April 2015 São Paulo, Brazil. Chairs: Scientific Co-ordinators: ESO - LATIN-AMERICAN PROGRAMME
ESO - LATIN-AMERICAN PROGRAMME MASTERCLASS IN CLINICAL ONCOLOGY 25-29 April 2015 São Paulo, Brazil Chairs: N. Pavlidis, GR - R.A. Stahel, CH Scientific Co-ordinators: M. Aapro, CH - F. Cardoso, PT FOREWORD
Breast. Patient information. cancer clinical pathway
Breast Patient information cancer clinical pathway This leaflet was written to properly inform people following breast cancer treatment plan. It doesn t replace the dialogue with healthcare staff; it rather
Lung Cancer and Pleural Mesothelioma: Cleveland Clinic Multidisciplinary Approaches to Care
Lung Cancer and Pleural Mesothelioma: Cleveland Clinic Multidisciplinary Approaches to Care Saturday, April 27, 2013 Cleveland Marriott Downtown at Key Center 127 Public Square Cleveland, Ohio Learning
Non Small Cell Lung Cancer: Scientific Discoveries and the Pursuit of Progress
Non Small Cell Lung Cancer: Scientific Discoveries and the Pursuit of Progress Lung Cancer Accounts for 14% of All New Cancer Diagnoses in the United States 1 Lung cancer is the second most common malignancy
URO. 19/20 March 2015. 4 th International Workshop. Madrid
URO 2015 4 th International Workshop ADVANCED PROSTHETIC UROGENITAL SURGERY IN THE TREATMENT OF POST-RADICAL PROSTATECTOMY SEQUELAE Madrid 19/20 March 2015 Puerta de Hierro-Majadahonda University Hospital
Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer in East tasia Chia-Chi (Josh) Lin, MD, PhD 林 家 齊 Director of Phase I Center, e Department of Oncology, National Taiwan University Hospital Clinical Associate Professor, Department
Scientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom
Scientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom Luca Gianni Fondazione Centro San Raffaele del Monte Tabor, Milan, Italy Ana Maria Gonzalez-Angulo M.D. Anderson Cancer
Future Directions in Clinical Research. Karen Kelly, MD Associate Director for Clinical Research UC Davis Cancer Center
Future Directions in Clinical Research Karen Kelly, MD Associate Director for Clinical Research UC Davis Cancer Center Outline 1. Status of Cancer Treatment 2. Overview of Clinical Research at UCDCC 3.
Advances in Lung Cancer: A Multidisciplinary Approach
Advances in Lung Cancer: A Multidisciplinary Approach Saturday, April 25, 2015 127 Public Square Cleveland, Ohio Learning Objectives About the Course This one-day course will provide a topical, clinically
PROJECT SUPPORT IN THE DESIGN OF PUBLIC-PRIVATE AGRICULTURAL RISK MANAGEMENT SYSTEM IN VIETNAM AECID- 2012/SPE/0400206
PROJECT SUPPORT IN THE DESIGN OF PUBLIC-PRIVATE AGRICULTURAL RISK MANAGEMENT SYSTEM IN VIETNAM AECID- 2012/SPE/0400206 IPSARD team visit to Spain 6 to 8 May 2015 Composition of IPSARD delegation: Name
8:50 Opening statement - Dr. Felipe José Fernández Coimbra (Head of the Department of Abdominal Surgery, Hospital A. C.
IV SYMPOSIUM OF THE GASTROINTESTINAL ONCOLOGY CONTINUING MEDICAL EDUCATION PROGRAM - DEPARTMENT OF ABDOMINAL SURGERY, SURGICAL ONCOLOGY, A. C. CAMARGO CANCER HOSPITAL ESOPHAGOGASTRIC CANCER AND GIST SCIENTIFIC
IMFP09. XXXVII International Meeting on Fundamental Physics. February 9 13, 2009. Centro de Ciencias de Benasque Pedro Pascual Benasque, Huesca, Spain
IMFP09 XXXVII International Meeting on Fundamental Physics February 9 13, 2009 Centro de Ciencias de Benasque Pedro Pascual Benasque, Huesca, Spain Final Bulletin The International Meeting on Fundamental
Madrid International Bariatric Endoscopy
2 nd international course Madrid International Bariatric Endoscopy www.mibemeeting.com MIBE 2015 Madrid International Bariatric Endoscopy 24 th and 25 th 2015 September Madrid Sanchinarro University Hospital
Department of Haematology University Hospital. University of Salamanca, Spain
Immunophenotyping of Plasma Cells: Implications on management Department of Haematology University Hospital Cancer Research Centre J.F. San Miguel University of Salamanca, Spain Faculty disclosure information
CURRICULUM VITAE 11/10/04
CURRICULUM VITAE 11/10/04 Ariana Diana RUS MD. PRESENT POSITION 2000-present Department of Physiology Faculty of Medicine University of Valencia PhD Student Cl/ Avda. Blasco Ibanez, 15 C.P. 46010 Valencia
How To Prepare A Lung Cancer Screening Course
Lung Cancer Screening Course 2015 Friday, May 8th, 2015 Languages: Spanish and English with simultaneous translation 32 International Conference on Lung Cancer Screening Saturday and Sunday, May 9-10,
PROGRAM. Afternoon 14:00-16:00 Works in groups (Tutors from each country). 16:15-17:00 Neuropathology. Danielle Seilhan
First Ramon y Cajal French-Spanish Summer Course on Neurodegenerative Diseases. Topic: Basal Ganglia and Parkinson s disease Collège d Espagne (Cité Internationale Universitaire de Paris) Paris, July 23-27th,
Minutes and mobility 2015
Steering Committee online meeting (Monday, 9 th March 2015) Minutes and mobility 2015 Table of content I. Agenda... 2 II. Participants... 2 III. Minutes... 3 IV. Mobility match of offers and applicants...
REPORT PERSPECTIVES IN LUNG CANCER 2010 AMSTERDAM
REPORT PERSPECTIVES IN LUNG CANCER 2010 AMSTERDAM Valerie Van Damme, Isabelle Wauters, Johan Vansteenkiste Univ. Hospital Leuven and Leuven Lung Cancer Group Introduction Perspectives in Lung Cancer (PILC)
SCIENTIFIC SECRETARY. - Richard Baird, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
PROGRAM CHAIRMEN - Bruce A. Chabner, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA - Hernán Cortés-Funes, Hospital Universitario 12 de Octubre, Instituto de Investigación i+12,
WORKSHOP ON THE CONSERVATION OF THE SUBTERRANEAN CULTURAL HERITAGE. Seville, Spain. 25-27 March 2014
WORKSHOP ON THE CONSERVATION OF THE SUBTERRANEAN CULTURAL HERITAGE Seville, Spain 25-27 March 2014 ORGANIZED BY TECHNOHERITAGE SPANISH NETWORK OF SCIENCE AND TECHNOLOGY FOR THE CONSERVATION OF CULTURAL
September 6th 2010 (Monday) Centro de Docencia Hospital Universitario Miguel Servet. Aula Edificio Consultas Externas. C/.
UPDATE IN THE MANAGEMENT OF GAUCHER DISEASE AND OTHER LYSOSOMAL DISORDERS PROGRAMME September 6-9th, 2010 Co-Directors Program MD, PhD - Miguel Servet University Hospital. CIBERER Miguel Pocovi, Profesor
Lung Cancer. Advances in Lung Cancer Treatment
Lung Cancer Advances in Lung Cancer Treatment Treatment for lung cancer is changing rapidly. There are new therapies that target specific molecular changes that drive the growth and spread of the lung
Social Cohesion in Europe
Social Cohesion in Europe February 4 th, 5 th, 2008 Universidad Carlos III de Madrid Scientific Committee: Gregorio Peces-Barba, Chairman (Universidad Carlos III de Madrid) Javier de Lucas (Director del
V Workshop on Cultural Economics and Management
2013 V Workshop on Cultural Economics and Management Cádiz, October 24th and 25 th 2013 Facultad CCEE y Empresariales Cádiz, October 24th and 25th 2013 www.uca.es/emprendedores/5wcem Call for papers The
29th- 30th October 2015 Hospital Universitario Virgen del Rocío
29th- 30th October 2015 Hospital Universitario Virgen del Rocío Welcoming The isurgitec conference was initiated in 2008 at Cursos de Verano de la Universidad Complutense de Madrid, El Escorial when four
STELLA 2014 Intercontinental Staff Mobility Programme
1. Brazil UNESP 1 000.00 Eliana Correa Contiero Board Academic 03/01 International Relations Office European Programs Coordination (Universidad Politécnica de Madrid, Spain) 2. Brazil UNESP 1 000.00 Ivani
A novel molecular mechanism involved in cancer development revealed by targeting MafB to hematopoietic progenitors
A novel molecular mechanism involved in cancer development revealed by targeting MafB to hematopoietic progenitors Carolina Vicente Dueñas Instituto de Biología Molecular y Celular del Cáncer (IBMCC) (CSIC-Universidad
The following information is only meant for people who have been diagnosed with advanced non-small cell
Important information for people with advanced non-small cell lung cancer The following information is only meant for people who have been diagnosed with advanced non-small cell lung cancer (NSCLC). NSCLC
Management of stage III A-B of NSCLC. Hamed ALHusaini Medical Oncologist
Management of stage III A-B of NSCLC Hamed ALHusaini Medical Oncologist Global incidence, CA cancer J Clin 2011;61:69-90 Stage III NSCLC Includes heterogeneous group of patients with differences in the
Theoretical part: Practical part:
HP Bueno.indd 1 06/09/13 14:41 The International Masters Degree in Pulmonary Hypertension is organized through the Universidad de Santiago de Compostela (Spain), the Spanish Society of Cardiology (Sociedad
TARRACO-MALACCA III JOINT WORKSHOP
TARRACO-MALACCA III JOINT WORKSHOP Venue: Hotel Guitart Gold Central Park Resort & Spa, Lloret de Mar Congress language: English/Spanish Organizing Committee: Dr. Joan J. Vendrell (University Hospital
METIE. Theory and International. Master in Economic. Economics. Official University. Postgraduate. Program. Degree. Madrid.
Postgraduate Program Official University Degree Master/60 ECTS Executive Program Madrid METIE Master in Economic Theory and International Economics Summary METIE Program Objectives / 2 Structure / 2 Courses
Best of San Antonio Breast Cancer Symposium
Best of San Antonio Breast Cancer Symposium 11:45 am - 5:00 pm 5800 Rockside Woods Blvd. About the Course The San Antonio Breast Cancer Symposium is an international meeting of laboratory and clinical
The Isabel Application
The Isabel Application Prof. Juan Quemada Dept. of Telematic Engineering Universidad Politécnica de Madrid ISABEL Advanced multiconferencing system 4Developed at UPM since 1993 (RACE/ACTS/IST) http://isabel.dit.upm.es
laura.bonanno@ioveneto.it Medical Oncology 2 Unit. Medical Oncology 2 Istituto Oncologico Veneto I.R.C.C.S
E UROPEAN C URRICULUM V ITAE PERSONAL DATA Name Laura Bonanno Work address Medical Oncology 2 I.O.V. Istituto Oncologico Veneto I.R.C.C.S. Via Gattamelata, 64 35128 Padova (IT) Telefono +390498215553/5931
Official University. Postgraduate. Program. Degree. in Macroeconometrics. Madrid. Master/60 ECTS. Executive Program. and Finance.
Postgraduate Program Official University Degree Master/60 ECTS Executive Program Madrid M3F Master in Macroeconometrics and Finance Summary M3F Program Objectives / 2 Structure / 2 Courses / 3 Directors
III CONFERENCE. Advances in research and treatment of Borderline Personality Disorder
III CONFERENCE Advances in research and treatment of Borderline Personality Disorder Barcelona 14 and 15 March 2013 Conference hall of the Official Medical College of Barcelona (COMB) Passeig de la Bonanova,
WORKSHOPS CURRE T TRE DS I BIOMEDICI E
WORKSHOPS CURRE T TRE DS I BIOMEDICI E 2013 SEDE A TO IO MACHADO BAEZA, SPAI MEMBRA E TRAFFIC AT THE SY APSE. THE CELL BIOLOGY OF SY APTIC PLASTICITY Baeza, Spain 7 th -9 th October 2013 Organized by:
Oxygen Requests List of Spanish Authorities
Oxygen Requests List of Spanish Authorities ANDALUCÍA MALAGA PROVINCE: Visitors to Marbella, Estepona or Manilva should send their documentation to: Hospital Costa del Sol Tel.: (+34) 951 976 663/4 Fax:
Chapter 7: Lung Cancer
Chapter 7: Lung Cancer Contents Chapter 7: Lung Cancer... 1 Small Cell... 2 Good PS + Limited stage... 2 Cisplatin/etoposide... 2 Concurrent chemotherapy + XRT... 2 Good / Intermediate PS... 2 Carboplatin
Regional Young Investigator SIC meeting. 5-6 March 2015
Regional Young Investigator SIC meeting 5-6 March 2015 Aula Magna A - Università Magna Graecia di Catanzaro - Campus Universitario S. Venuta Viale Europa, loc. Germaneto - Catanzaro Invited speakers: Rita
The EGFR mutation and precision therapy for lung cancer
for lung cancer Outcomes in advanced lung cancer have seen meaningful improvement in the past decade thanks to new precision drug therapies. Because tumors usually develop resistance to the drugs, scientists
Madrid LNG & SHIPPING Forum
The Premier International LNG & SHIPPING conference in Spain Madrid LNG & SHIPPING Forum 2 nd Edition 30 th 31 st May. Hotel Husa Princesa, Madrid SUMMIT GUIDE Host Sponsors www.ingenierojorgejuan.com/lng_madrid
Innovation: Present Meets Future
Innovation: Present Meets Future SOCIAL INNOVATION Leading Innovation in the Cooperative Group Setting Craig Nichols, M.D. BEST OF SWOG Barlogie-Salmon Myeloma Committee Robert Z. Orlowski, M.D., Ph.D.
Biomedicine The background. The main interest. The tools
1 Biomedicine The background The main interest? Bioinformatics Clinical informatics The tools 2 Outline 3 Outline 4 Working on Network Data Analysis HH RR Infrastructure Training BIOCOMPUTATION & STRUCTURAL
Applications of comprehensive clinical genomic analysis in solid tumors: obstacles and opportunities
Applications of comprehensive clinical genomic analysis in solid tumors: obstacles and opportunities Vincent A. Miller, M.D. Foundation Medicine, Inc. AACR Annual Meeting 2012 Current Concepts session
Harmesh Naik, MD. Hope Cancer Clinic HOW DO I MANAGE STAGE 4 NSCLC IN 2012: STATE OF THE ART
Harmesh Naik, MD. Hope Cancer Clinic HOW DO I MANAGE STAGE 4 NSCLC IN 2012: STATE OF THE ART Goals Discuss treatment options for stage 4 lung cancer: New and old Discuss new developments in personalized
GOLNIK 17/06/10 COURSE ON LUNG CANCER AND MESOTHELIOMA. 17-18 June 2010 Golnik, Slovenia. Chair: T. Cufer, SI - G.L. Ceresoli, IT
ESO ADVANCED COURSES, SEMINARS AND SYMPOSIA GOLNIK 17/06/10 COURSE ON LUNG CANCER AND MESOTHELIOMA 17-18 June 2010 Golnik, Slovenia Chair: T. Cufer, SI - G.L. Ceresoli, IT AIM OF THE COURSE The incidence
International Meeting: Improving water accounting at the basin scale. Agenda
Agenda Date: 23-24 th February 2015 Venue: Department of Civil Engineering, Meeting Room D-19, first floor, ETSINO Building (Annex), Universidad Politécnica de Cartagena, Paseo Alfonso XIII 52, Cartagena,
POLICY A. INDICATIONS
Alimta (pemetrexed) Line(s) of Business: HMO; PPO; QUEST Integration Akamai Advantage Original Effective Date: 09/01/2007 Current Effective Date: 10/01/2015 POLICY A. INDICATIONS The indications below
INTERNATIONAL DIPLOMA IN SERVICES MARKETING STRATEGIES
INTERNATIONAL DIPLOMA IN SERVICES MARKETING STRATEGIES INTERNATIONAL SUMMER COURSE IN SPAIN JULY 2013, MONDAY 1ST TO FRIDAY 5TH ] To ensure that we deliver our programs most effectively and with maximum